About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 157 trials

CompletedSafety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine in a 12-week treatment study if MEM 1003 is a safe and effective treatment for patients with mild to moderate Alzheimer's disease.NCT00257673·Northport, Alabama and 56 others CompletedThe Music, Sleep and Dementia StudyThe specific aims of this studyare to examine the 1) feasibility; 2) acceptability; and 3) preliminary efficacy of a tailored music intervention in home-dwelling older adults with…NCT04157244·Philadelphia, Pennsylvania

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedHealthy Aging and Memory StudyThis project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention…NCT00034567·Birmingham, Alabama and 38 others

CompletedADNI: Alzheimer's Disease Neuroimaging InitiativeThe purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early…NCT00106899·Birmingham, Alabama and 58 others

TerminatedA Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseThe primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the…NCT05310071·Gilbert, Arizona and 264 others

CompletedValproate in Dementia (VALID)The purpose of this trial is to demonstrate whether valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who…NCT00071721·Sun City, Arizona and 45 others

TerminatedA Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of CNP520, in people at…NCT03131453·Phoenix, Arizona and 193 others

TerminatedStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsThis is a study to evaluate the efficacy and safety of multiple doses of bapineuzumab in patients with mild to moderate Alzheimer Disease.NCT00667810·Birmingham, Alabama and 345 others

CompletedWeCareAdvisor Study for Caregivers of People Living With DementiaThe WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia.NCT05012410·Philadelphia, Pennsylvania

UnknownEvaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's…NCT00088673·Peoria, Arizona and 66 others

CompletedMemory Aid for Informed Consent in Alzheimer's ResearchThe purpose of this trial is to test whether a memory and organizational aid in the form of a document that summarizes and simplifies a study's key points can improve the…NCT00105612·Philadelphia, Pennsylvania

TerminatedA Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild…NCT03114657·Scottsdale, Arizona and 210 others

CompletedClinical Evaluation of Flortaucipir F 18This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET…NCT02278367·Phoenix, Arizona and 4 others

Active not recruitingLongitudinal Early-onset Alzheimer's Disease Study ProtocolThe Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals…NCT03507257·Sun City, Arizona and 22 others

CompletedADvance DBS-f in Patients With Mild Probable Alzheimer's DiseaseThe primary objective of this feasibility study is to evaluate the safety of DBS-f in patients with mild Alzheimer's disease by assessing all device and/or therapy related adverse…NCT01608061·Phoenix, Arizona and 6 others

CompletedA Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseThe purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion…NCT00818662·Birmingham, Alabama and 40 others

CompletedEffect of LY450139 on the Long Term Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00594568·Birmingham, Alabama and 147 others

TerminatedA Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the long-term safety and tolerability of Bapineuzumab (AAB-001, ELN115727) in subjects with Alzheimer's disease who participated in study…NCT00937352·Birmingham, Alabama and 190 others

CompletedEfficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of T-817MA in AD patients to treat dementia.NCT00663936·Phoenix, Arizona and 34 others

CompletedENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)The purpose of this study was to evaluate the safety and efficacy of revusiran (ALN-TTRSC) in patients with transthyretin (TTR) mediated Familial Amyloidotic Cardiomyopathy.NCT02319005·Bakersfield, California and 60 others

PreviousPage 3 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia